Epicutaneous immunity and onset of allergic diseases-per-"eczema"tous sensitization drives the allergy march

Allergology International

Volumn 62, Issue 3, 2013, Pages 291-296

  Matsumoto, Kenji ^a   Saito, Hirohisa ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Alarmin; Allergy march; Eczema; Epicutaneous sensitization; Food allergy

Indexed keywords

ALARMIN; FOOD ALLERGEN; FUNGAL PROTEIN; FUNGUS ANTIGEN; HISTAMINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 33; NEUROTOXIN; POLLEN ANTIGEN; PROTEIN; PROTEINASE; SUPERANTIGEN; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; ALLERGEN;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGY MARCH; ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; DAMAGE ASSOCIATED MOLECULAR PATTERN; DISEASE COURSE; ECZEMA; EPIDEMIOLOGICAL DATA; EXPOSURE; FOOD ALLERGY; FOOD INTAKE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; KERATINOCYTE; LANGERHANS CELL; MALASSEZIA GLOBOSA; NONHUMAN; PERMEABILITY BARRIER; PH; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHINOCONJUNCTIVITIS; RISK FACTOR; SENSITIZATION; SKIN INJURY; STAPHYLOCOCCUS AUREUS; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; PATHOLOGY; SKIN;

ALLERGENS; ANIMALS; ECZEMA; HUMANS; HYPERSENSITIVITY; SKIN;

EID: 84884325681     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.13-RAI-0603     Document Type: Review

References (60)

1. Baba M, Yamaguchi K. "The allergy march": Can it be prevented? Allergy & Clinical Immunology News 1989;1: 71-3.
2. Winkler AW, Lavietes PH, Robbins CL, Man EB. Tolerance to oral thyroid and reaction to intravenous thyroxine in subjects without myxedema. J Clin Invest 1943;22:535-44.
3. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
4. Atarashi K, Tanoue T, Shima T et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-41.
5. Du Toit G, Katz Y, Sasieni P et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008;122:984-91.
6. Greer FR, Sicherer SH, Burks AW. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008; 121:183-91.
7. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev 2012;9:CD000133.
8. Lack G, Fox D, Northstone K, Golding J. Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003;348:977-85.
9. Peeters KA, Knulst AC, Rynja FJ, Bruijnzeel-Koomen CA, Koppelman SJ. Peanut allergy: sensitization by peanut oil-containing local therapeutics seems unlikely. J Allergy Clin Immunol 2004;113:1000-1.
10. Perry TT, Conover-Walker MK, Pomes A, Chapman MD, Wood RA. Distribution of peanut allergen in the environment. J Allergy Clin Immunol 2004;113:973-6.
11. Brough HA, Santos AF, Makinson K et al. Peanut protein in household dust is related to household peanut consumption and is biologically active. J Allergy Clin Immunol. DOI: 10.1016 j.jaci.2013.02.034.
12. Fox AT, Sasieni P, du Toit G, Syed H, Lack G. Household peanut consumption as a risk factor for the development of peanut allergy. J Allergy Clin Immunol 2009;123:417-23.
13. Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008;121:1331-6
14. Brown SJ, Asai Y, Cordell HJ et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011;127:661-7.
15. Japanese Society of Allergology. Meeting Report of the Special Committee for the Safety of Protein Hydrolysates in Cosmetics. Available at: http://www.jsaweb.jpmodulesenindex.php?content_id=11. Accessed July 18, 2013.
16. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy 2005;35:757-66.
17. Senti G, Graf N, Haug S et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009;124:997-1002.
18. Moingeon P, Mascarell L. Novel routes for allergen immunotherapy: safety, efficacy and mode of action. Immunotherapy 2012;4:201-12.
19. Dioszeghy V, Mondoulet L, Dhelft V et al. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol 2011;186:5629-37.
20. Li W, Zhang Z, Saxon A, Zhang K. Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model. Allergy 2012;67:622-9.
21. Nagao K, Kobayashi T, Moro K et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol 2012;13: 744-52.
22. Tomura M, Honda T, Tanizaki H et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 2010;120:883-93.
23. + Treg cells that inhibit Tc1-mediated CS. Immunol Cell Biol 2012;90:784-95.
24. Mondoulet L, Dioszeghy V, Puteaux E et al. Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice. Clin Transl Allergy 2012;2:22.
25. Wetzig H, Schulz R, Diez U, Herbarth O, Viehweg B, Borte M. Associations between duration of breastfeeding, sensitization to hens' eggs and eczema infantum in one and two year old children at high risk of atopy. Int J Hyg Environ Health 2000;203:17-21.
26. Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW. Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ 1996;313:514-7.
27. Lai CC, Yan DC, Yu J, Chou CC, Chiang BL, Hsieh KH. Latex allergy in hospital employees. J Formos Med Assoc 1997;96:266-71.
28. Matsumoto K, Shimanouchi Y, Kawakubo K et al. Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age. Int Arch Allergy Immunol 2005;137(Suppl 1):69-76.
29. Hopper JL, Bui QM, Erbas B et al. Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol 2012;130:1117-22.
30. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis-a prospective follow-up to 7 years of age. Allergy 2000;55:240-5.
31. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-6.
32. Oyoshi MK, Murphy GF, Geha RS. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009;124:485-93.
33. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998;28:769-79.
34. Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol 2010;126: 976-84.
35. Ino Y, Ando T, Haida M et al. Characterization of the proteases in the crude mite extract. Int Arch Allergy Appl Immunol 1989;89:321-6.
36. Stewart GA, Thompson PJ, Simpson RJ. Protease antigens from house dust mite. Lancet 1989;2:154-5.
37. Nakamura T, Hirasawa Y, Takai T et al. Reduction of skin barrier function by proteolytic activity of a recombinant house dust mite major allergen Der f 1. J Invest Dermatol 2006;126:2719-23.
38. Jeong SK, Kim HJ, Youm JK et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008;128:1930-9.
39. Morita H, Arae K, Ohno T et al. ST2 requires Th2-, but not Th17-, type airway inflammation in epicutaneously antigen-sensitized mice. Allergol Int 2012;61:265-73.
40. Moniaga CS, Jeong SK, Egawa G et al. Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice. Am J Pathol 2013;182:841-51.
41. Jolly HW Jr, Hailey CW, Netick J. pH determinations of the skin. Readings under normal and abnormal conditions. J Invest Dermatol 1961;36:305-8.
42. Jungersted JM, Scheer H, Mempel M et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 2010;65:911-8.
43. Hachem JP, Man MQ, Crumrine D et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005;125:510-20.
44. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008;122:689-93.
45. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
46. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007;81:59-66.
47. Yang D, Chen Q, Su SB et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 2008;205:79-90.
48. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008;3:e3331.
49. Luthi AU, Cullen SP, McNeela EA et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009;31:84-98.
50. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 2011; 186:2523-8.
51. Nakae S, Morita H, Ohno T, Arae K, Matsumoto K, Saito H. Role of interleukin-33 in innate-type immune cells in allergy. Allergol Int 2013;62:13-20.
52. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
53. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
54. Neuber K, Steinrucke K, Ring J. Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-gamma, interleukin-4 and interleukin-5 production in atopic eczema. Int Arch Allergy Immunol 1995;107:179-82.
55. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000;105:782-7.
56. Elentner A, Finke D, Schmuth M et al. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med 2009; 13:2658-72.
57. + dermal dendritic cells. Immunity 2008;29:497-510.
58. Nakajima S, Igyarto BZ, Honda T et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012;129:1048-55.
59. Mudde GC, van Reijsen FC, Bruijnzeel-Koomen CA. IgEpositive Langerhans cells and Th2 allergen-specific T cells in atopic dermatitis. J Invest Dermatol 1992;99:103S.
60. Novak N, Valenta R, Bohle B et al. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 2004;113:949-57.